Abstract
The authors consider the possible correlations between certain alterations of the neurotransmitters of the central nervous system and two common clinical syndromes: schizophrenia and depression.
Psychic life is not an abstract world which lives of itself, but rather a set of activities tightly bound to the life of the organism, which are subject to the influence of the latter and in turn affect the activity of the organic functions.
Mario Gozzano
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Afro Publio Terenzio. Phormio. (160 a. C.) Atto IV, scena prima, 9.
Eugen B. Dementia praecox, oder Gruppe der Schizophrenien. Leipzig: Duticke Verlag; 1911.
Herman W. The Caine Mutiny. New York: Doubleday Publisher; 1951.
Aiazzi Mancini M, Donatelli L. Trattato di farmacologia. Milano: Francesco Vallardi Editore; 1969.
Bernsohn J, Namajuk J, Cchrane LS. Inhibition of brain cytochrome oxidase and ATP-ase by chloropromazine analogues. Proc Soc Exp Biol Med. 1956;92:201–3.
Laborit H. Les Régulations metaboliques. Paris: Masson & Cie Editeurs; 1965.
Laborit H, Huguenard P, Allaume R. Un nouvou stabilisateurr vegetatif : le 4560 RP (chloropromazine). Presse méd. 1952;60(10):206–8.
Bear MF, Connors BW, Paradiso MA. Neuroscience: exploring the brain—third edition. New York: Lippincot Williams & Wilkins; 2007.
Meltzer HY. Clinical studies on the mechanism of action of clozapine: the dopamine-serotonin hypothesis of schizophrenia. Psychopharmacology. 1989;99(1., Supplement):S18–27.
Coyle JT, et al. Beyond the dopamine receptor: novel therapeutic targets for treating schizophrenia. Dialogues Clin Neurosci. 2010;12(3):359–82.
Kartvelishvily E, Shleper M, et al. Neuronderived D-serine release provides a novel means to activate N-methyl-D-aspartate receptors. J Biol Chem. 2006;281:14151–62.
Caulfield MP, Birdsall NJ. International Union of Pharmacology, XVII. Classification of muscarinic receptors. Pharmacol Rev. 1998;50:279–90.
Shekhar A, Potter WZ, Lightfoot J, et al. Selective muscarinic receptors agonist xanomeline as a novel treatment approach for schizophrenia. Am J Psychiatry. 2008;165:1033–9.
Figiel G, Sadowsky C. A systematic review of the effectiveness of rivastigmine for the treatment of behavioral disturbances in dementia and other neurologic disorders. Curr Med Res Opin. 2008;24:157–66.
Grossberg GT. Effect of rivastigmine in the treatment of behavioral disturbances associated with dementia; review of neuropsychiatric impairment in Alzheimer’s disease. Curr Med Res Opin. 2005;21:1631–9.
Dean B, McLeod M, Keriakous D, McKenzie J, Scarr E. Decreased muscarinic1 receptors in the dorsolateral prefrontal cortex of subjects with schizophrenia. Mol Psychiatry. 2002;7:1083–91.
KSP A, Höglund AU. Intravenously administered oxotremorine and atropine, in doses known to affect pain threshold, affect the intraspinal release of acetylcholine in rats. Pharmacol Toxicol. 2002;90:187–92.
Bartolini A, Ghelardini C, Fantetti L, et al. Role of muscrinic receptor subtypes in central antinoception. Br J Pharmacol. 1992;105:77–82.
Baba H, et al. Muscarinic facilitation of GABA release in substantia gelatinosa of the rat spinal dorsal horn. J Physiol. 1998;508:83–93.
Yegin A, Yilmaz M, Karsli B, Erman M. Analgesic effects of intrathecal neostigmine in perianal surgery. Eur J Anaesthesiol. 2003;20:404–8.
Gupta S. Postoperative analgesia with intrathecal neostigmina; two 75 mcg and 50 mcg with heavy bupivacaine. Internet J Anesthesiol. 2008;25:1.
Kaya FN, Sahin S, Owen MD, Eisenach JC. Epidural neostigmine produces analgesia but also sedation in women after caesarean delivery. Anesthesiology. 2004;100:381–5.
Lauretti GE, De Oliveira R, Reis MP, et al. Study of three different doses of epidural neostigmina coadministered with lidocaine for postoperative analgesia. Anesthesiology. 1999;90(6):1534–8.
Buaziz H, Paqueron X, Bur ML, Merle M, Laxenaire MC, Benhamou D. No enhancement of sensory and motor blockade by neostigmine added to mepivacaina axillary plexus. Anesthesiology. 1999;91(1):78–83.
Alemanno F, Ghisi D, Westermann B, Bettoni A, Fanelli A, LaColla L, Danelli G, Cesana BM. The use of vitamin B1 as a perineural adjuvant to the Middle Interscalene Block for postoperative analgesia after shoulder surgery. Acta Biomed. 2016;87(1):22–7.
Kumary V, Postma V. Nicotine use in schizophrenia: the self-medication hypothesis. Neurosci Biobehav Rev. 2005;6(29):1021–34.
Gray R, Rajan AS, Radcliffe KA, Yakeiro M, Dani JA. Hippocampal synaptic transmission enhanced by low concentrations of nicotine. Nature. 1996;383:713–6.
Von Euler US, Gaddum JH. An unidentified depressor substance in certain tissue extracts. J Physiol. 1931;72(1):74–87.
Massoni E, Bersani G. Possibile ruolo della sostanza P e del suo recettore NK1 nei disturbi dell’umore ed in condizioni psichiatriche. Riv Psichiatr. 2003;38(6):289–95.
Sergeyev V, Hokfelt T, Hurd Y. Serotonin and substance P co-exist in dorsal raphe neurons of the human brain. Neuroreport. 1999;10:3967–70.
Roberts GW, et al. Peptides, the limbic lobe and schizophrenia. Brain Res. 1983;288:199–211.
Tezzon Frediano (Head Neurologist, Merano General Hospital). Comment on re-reading this chapter (in the text). March 2016.
Bellucci G. Storia dell’Anestesiologia. Padova: Piccin Editore; 1982. p. 389–92.
Bondy B, Baghai TC, et al. Substance P serum levels are increased in major depression: preliminary results. Biol Psychiatry. 2003;53(6):538–42.
Keller M, Montgomery S. Lack of efficacy of the substance P (Neurokinin1 receptor) antagonist aprepitant in the treatment of major depressive disorder. Biol Psychiatry. 2006;59:216–23.
Stout SC, Owens MJ, Nemeroff CB. Neurokinin (1) receptor antagonists as potential antidepressant. Ann Rev Pharmacol Toxicol. 2001;41:877–906.
Nemeroff CB, Widerlov E, Bisette G, Nemeroff CB. Elevated concentrations of CSF corticotropin releasing factor-like immunoreactivity in depressed patients. Science. 1984;22:1343–4.
Galeno di Pergamo, De Tumoribus. Citato in: Cosmacini G, Sironi VA. Il male del secolo, per una storia del cancro. Roma-Bari: Laterza Editore; 2002.
Sirtori C. Atti del “Symposium Cancro del Polmone”. Introduzione biologica generale. Milano, Ospedale Maggiore “Ca Granda”, 22 giugno 1968.
Laborit H. Elogio della fuga. Milano: Mondadori; 1982.
Laborit H. La colombe assasinée. Paris: Editions Grusset & Fasquelle; 1983.
Further Reading
Axelsson K, Gupta A. Local anaesthetic adjuvants: neuraxial versus peripheral nerve blocks. Curr Opin Anaesthesiol. 2009;22:649–54.
Bear MF, Connors BW, Paradiso MA. Neuroscienze: Esplorando il cervello. Milano: Elsevier – Masson; 2009.
Brown JL, et al. Morphological characterization of substance P receptor-immunoreactive neurons in the rat spinal cord and trigeminal nucleus caudalis. J Comp Neurol. 1995;356:327–44.
Bymaster FP, Carter PA, Yamada M, et al. Role of specific muscarinic receptor subtypes in cholinergic parasympathomimetic responses, in vivo phosphoinositide hydrolysis, and pilocarpine-induced seizure activity. Eur J Neurosci. 2003;17:1403–10.
Frotscher M, Leranth C. Cholinergic innervation of the rat hippocampus as revealed by choline acetyltransferase immunocytochemistry; a combined light and electron microscopic study. J Comp Neurol. 1985;239:237–46.
Galzigna L. Il Cervello dell’Uomo. Ferrara: Corso Editore; 1976.
Gillespie CF, Nemeroff CB. Hypercortisolemia and depression psychosomatic medicine. J Biobehav Med. 2005;67:S26–8.
Gozzano M. Compendio di psichiatria. Torino: Rosenberg & Sellier; 1964.
Heim C, Newport DJ, Bonsall R, Miller AH, Nemeroff CB. Altered pituitary-adrenal axis responses to provocative challenge tests in adult survivors of childhood abuse. Am J Psychiatry. 2001;158:575–81.
Hood DD, Eisenach JC, Tuttle RRN. Phase I. Safety assessment of intrathecal neostigmine methylsulfate in humans. Anesthesiology. 1995;82:331–43.
Kramer MS, Winokur A, et al. Demonstration of the efficacy and safety of a novel substance P (NK1) receptor antagonist in major depression. Neuropsychopharmacology. 2004;29(2):385–92.
Labrie V, Fukumura R, Rastogi A, et al. Serine racemase is associated with schizophrenia susceptibility in humans and in a mouse model. Hum Mol Genet. 2009;18:3227–43.
Lewis DA, Fashimoto T, Volk DW. Cortical inhibitory neurons and schizophrenia. Nat Rev. Neurosci. 2005;6:312–24.
Morita Y, Ujike H, Tanaka Y, Otani K, et al. A genetic variant of serine racemase gene is associated with schizophrenia. Biol Psychiatry. 2006;61:1200–3.
Murphy DB, McCartney CJ, Chan VW. Novel analgesic adjuncts for brachial plexus block: a systematic review. Anesth Analg. 2000;90:1122–8.
Schwarz MJ, Ackenheil M. The role of substance P in depression. Dialogues Clin Neurosci. 2002;4(1):21–9.
Spokes EG. An analysis of factors influencing measurements of dopamine, noradrenaline, glutamate decarboxylase and choline acetylase in human post- mortem brain tissue. Brain. 1979;102:333–46.
Toru M, et al. Neurotransmitters, receptors and neuropeptides in post-mortem brains of chronic schizophrenic patients. Acta Psychiatr Scand. 1988;78:121–37.
Kramer MS, Winokur A, et al. Demonstration of the efficacy and safety of a novel substance P (NK 1) receptor antagonist in major depression. Neuropsychopharmacology. 2004;29:385–92.
Wolosker H, Blackshaw S, Snyder SH. Serine racemase: a glial enzyme synthesizing D-serine to regulate glutamate-N-methyl-D-aspartate neurotransmission. Proc Natl Sci U S A. 1999;96:13409–14.
www.psicologi-italia.it/.../depressione/1081/depressione-serotonina.html
Yaksh TI, Dirksen R, Haty GJ. Antinoceptive effects of intrathecally injected cholinomimetic drugs in the rat and cat. Eur J Pharmacol. 1985;117:81–8.
Zhang Y, Behrens MM, Lisman JE. Prolonged exposure to NMDA antagonist suppresses inhibitory synaptic transmission in prefrontal cortex. J Neurophysiol. 2008;100:959–65.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Alemanno, F., Alemanno, F. (2020). When the Mind Does Not Work as It Should. In: Alemanno, F. (eds) Biochemistry for Anesthesiologists and Intensivists. Springer, Cham. https://doi.org/10.1007/978-3-030-26721-6_11
Download citation
DOI: https://doi.org/10.1007/978-3-030-26721-6_11
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-26720-9
Online ISBN: 978-3-030-26721-6
eBook Packages: MedicineMedicine (R0)